Literature DB >> 19249434

Coronary artery fistula associated with Kawasaki disease.

Chi-Di Liang1, Ho-Chang Kuo, Kuender D Yang, Chih-Lu Wang, Sheung-Fat Ko.   

Abstract

BACKGROUND: The aim of this study was to investigate the rate, risks factors, and clinical impact of coronary artery fistula (CAF) in Kawasaki disease (KD).
METHODS: From February 1999 to December 2007, a total of 325 pediatric patients fulfilled the diagnostic criteria of KD and admitted for intravenous immunoglobulin treatment were enrolled in this study. Patients with and without CAF were designated as group 1 and group 2, respectively. Patients of group 1 were further subdivided as with and without coronary artery lesions (CALs). The clinical presentations, laboratory data, and outcomes were compared among the groups.
RESULTS: The mean age of the 325 patients was 21.1 months. Group 1 had 17 patients, and group 2 had 308 patients. The rate of CAF in KD was 5.3%. There were significant differences between group 1 and group 2 patients regarding age (11.8 +/- 1.8 vs 21.5 +/- 1.2 months, P = .01), the presence of CAL (64.7% vs 25%, P < .01), white blood cell counts (16.4 +/- 1.3 vs 13.5 +/- 0.3 x 10(3)/mm(3), P = .01), and platelet counts (432.1 +/- 39.1 vs 346.4 +/- 8.4 x 10(3)/mm(3), P = .02). Spontaneous closure of CAF was observed in 7 (41%) of the 17 patients during follow-up (mean 45 months). Group 1 patients without CAL had a more benign clinical course (total fever day 5.8 +/- 0.6 vs 8.6 +/- 0.8, P = .03) and higher spontaneous closure rate (5/6 vs 2/11, P = .035) than patients with CAL.
CONCLUSIONS: Patients of young age, CAL, high white blood cell counts, and high platelet counts have higher rate of CAF formation. Approximately 5% KD patients may associate with CAF, but most of them have good clinical outcome during follow-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249434     DOI: 10.1016/j.ahj.2008.11.020

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  31 in total

Review 1.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

2.  Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.

Authors:  Ying-Jui Lin; I-Chun Lin; Hong-Ren Yu; Hsuan-Chang Kuo; Kuender D Yang; Wei-Chiao Chang; Chi-Di Liang; Shih-Feng Liu; Ho-Chang Kuo
Journal:  Pediatr Cardiol       Date:  2012-07-19       Impact factor: 1.655

3.  Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese children.

Authors:  Ho-Chang Kuo; Ying-Jui Lin; Suh-Hang Hank Juo; Yu-Wen Hsu; Wei-Chiao Chen; Kuender D Yang; Chi-Di Liang; Shengyu Yang; Mei-Chyn Chao; Hong-Ren Yu; Shouyan Wang; Li-Yan Lin; Wei-Chiao Chang
Journal:  J Clin Immunol       Date:  2011-04-13       Impact factor: 8.317

4.  Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study.

Authors:  H-C Kuo; W-C Chang; L-J Wang; S-C Li; W-P Chang
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-22       Impact factor: 6.892

5.  CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Chi-Di Liang; Hong-Ren Yu; Chih-Lu Wang; I-Chun Lin; Chieh-An Liu; Jen-Chieh Chang; Chiu-Ping Lee; Wei-Chiao Chang; Kuender D Yang
Journal:  J Clin Immunol       Date:  2010-11-17       Impact factor: 8.317

6.  ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.

Authors:  Ho-Chang Kuo; Kuender D Yang; Suh-Hang Hank Juo; Chi-Di Liang; Wei-Chiao Chen; Yu-Shiuan Wang; Chih-Hung Lee; Edward Hsi; Hong-Ren Yu; Peng-Yeong Woon; I-Chun Lin; Chien-Fu Huang; Daw-Yang Hwang; Chiu-Ping Lee; Li-Yan Lin; Wei-Pin Chang; Wei-Chiao Chang
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

7.  DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease.

Authors:  Hong-Ren Yu; Wei-Pin Chang; Lin Wang; Ying-Jui Lin; Chi-Di Liang; Kuender D Yang; Chiu-Ming Kuo; Yi-Chuan Huang; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  ScientificWorldJournal       Date:  2012-05-02

8.  Association of the resistin gene promoter region polymorphism with Kawasaki disease in Chinese children.

Authors:  Ruixi Liu; Bo He; Fang Gao; Qian Liu; Qijian Yi
Journal:  Mediators Inflamm       Date:  2012-04-08       Impact factor: 4.711

9.  Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study.

Authors:  Ho-Chang Kuo; Wei-Chiao Chang; Kuender D Yang; Hong-Ren Yu; Chih-Lu Wang; Shu-Chen Ho; Chun-Yuh Yang
Journal:  BMC Pediatr       Date:  2013-03-23       Impact factor: 2.125

10.  Non-Typhoidal Salmonella and the Risk of Kawasaki Disease: A Nationwide Population-Based Cohort Study.

Authors:  Thomas Yen-Ting Chen; Mei-Chia Chou; Jung-Nien Lai; Lu-Ting Chiu; Renin Chang; Yao-Min Hung; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.